paper
overview
assess
new
commerci
avail
veterinari
vaccin
place
histor
context
author
critic
evalu
current
state
field
veterinari
vaccin
food
companion
anim
promis
futur
vaccin
develop
author
maintain
consider
variabl
safeti
sustain
efficaci
among
veterinari
vaccin
especi
develop
companion
anim
propos
establish
intern
vaccin
advisori
committe
support
would
function
appris
veterinari
profess
current
statu
vaccin
use
q
cet
articl
survol
en
le
nouveaux
vaccin
dispon
sur
le
et
dan
leur
context
historiqu
le
auteur
exerc
leur
critiqu
quant
la
situat
du
secteur
de
vaccin
la
foi
dan
le
ca
de
animaux
de
compagni
et
de
ferm
il
soutienn
quil
subsist
de
variat
au
niveau
de
la
et
de
de
vaccin
notam
ceux
aux
animaux
de
compagni
il
propos
lorganis
dun
consultatif
intern
dont
le
serait
dinform
la
profess
de
la
situat
actuel
de
vaccin
et
de
leur
emploi
q
paper
repres
brief
commentari
assess
new
commerci
avail
veterinari
vaccin
place
histor
context
meant
comprehens
reader
refer
book
paulpierr
pastoret
other
complet
treatis
conditio
sine
qua
non
vaccin
safeti
sustain
efficaci
howev
consider
variabl
paramet
among
veterinari
vaccin
especi
develop
companion
anim
includ
equin
ideal
vaccin
safe
well
effect
emphasi
tend
differenti
place
vaccin
produc
food
anim
compar
pet
companion
anim
untoward
effect
accept
food
anim
long
vaccin
give
good
herd
flock
protect
untoward
effect
far
less
accept
pet
anim
focu
health
individu
anim
lead
licens
vaccin
littl
efficaci
latter
group
long
caus
harm
may
result
differenti
econom
pressur
present
food
anim
field
versu
companion
anim
former
produc
livelihood
depend
upon
efficaci
cost
vaccin
vaccin
perform
expect
cost
judg
high
especi
industri
low
profit
margin
poultri
vaccin
use
companion
anim
medicin
econom
pressur
produc
efficaci
costeffect
vaccin
usual
signific
result
differenti
econom
pressur
demand
safe
vaccin
somewhat
equival
product
anim
companion
anim
medicin
qualiti
vaccin
latter
may
vari
consider
econom
imper
result
rigor
evalu
vaccin
develop
market
use
product
anim
agricultur
howev
without
effect
oversight
bodi
vaccin
use
companion
anim
especi
dog
cat
often
rigor
evalu
data
support
efficaci
claim
often
incomplet
defici
also
train
veterinari
practition
frequent
inadequ
permit
individu
critic
assess
vaccin
safeti
efficaci
data
exist
unfortun
rigor
scientif
approach
develop
veterinari
vaccin
often
lack
develop
often
empir
shaman
therapi
occasion
efficaci
develop
long
histori
trial
error
worst
case
lack
rigor
result
sale
vaccin
lack
efficaci
inappropri
anim
certain
local
although
legisl
regul
place
help
assur
safeti
efficaci
adequ
recent
avma
council
recommend
approach
address
issu
need
system
report
vaccin
advers
event
similar
human
clearli
requir
ford
task
forc
immun
aaha
j
publish
standard
vaccin
vaccin
strain
detail
knowledg
safeti
efficaci
potenc
durat
immun
need
ration
recommend
truli
made
propos
intern
vaccin
advisori
committe
establish
would
function
appris
veterinari
profess
current
statu
vaccin
use
support
initi
organ
intern
associ
biolog
standard
would
worthwhil
step
immun
peopl
protect
diseas
histor
trace
attempt
mithrid
vi
ancient
greek
king
pontu
centuri
bc
protect
poison
repeat
consumpt
small
amount
poison
substanc
honey
theriaca
account
whether
actual
protect
real
attempt
veterinari
vaccinolog
somewhat
paradox
efficaci
vaccin
exist
sever
anim
diseas
use
sinc
vaccin
would
mitig
current
protocol
surveil
eg
bovin
tuberculosi
other
like
african
swine
fever
effect
vaccin
sinc
introduct
variol
near
east
earli
centuri
subsequ
use
cowpox
viru
variola
first
veterinari
vaccin
pasteur
prepar
immun
chicken
fowl
cholera
public
concern
safeti
efficaci
vaccin
chang
attitud
toward
anim
valu
health
care
provok
vigor
widespread
discuss
use
vaccin
especi
small
anim
practic
ideal
world
industri
govern
regulatori
offici
veterinari
profess
would
address
real
presum
problem
companion
anim
vaccin
quickli
respons
soon
identifi
unfortun
problem
often
neglect
avoid
circumst
contribut
confus
creation
myth
often
enhanc
differ
view
expert
form
conclus
limit
data
bias
sampl
design
misfortun
vaccin
well
document
ref
often
becom
elev
catastroph
especi
holist
faith
sic
advoc
radic
philosophi
ignor
benefit
provid
vaccin
concern
occasion
led
senseless
conclus
vaccin
danger
direct
indirect
caus
chronic
ill
vaccinosi
vaccinos
claim
rang
devast
immun
system
lazi
bowel
diseas
bloat
stain
teeth
ulcer
chronic
gastroenter
autoimmun
hemolyt
anaemia
seizur
list
condit
cite
question
commonli
ask
dog
ownersbreed
veterinarian
usual
complex
includ
vaccin
avail
dog
necessari
vaccin
safe
young
pup
effect
prevent
diseasedo
live
inactiv
vaccin
produc
steril
immun
interrupt
transmiss
soon
immun
occur
vaccin
long
endur
vaccin
continu
develop
diseas
still
poorli
understood
mani
agent
packag
multicompon
vaccin
consequ
well
establish
immun
system
respond
normal
sever
differ
antigensan
issu
seem
persist
howev
combin
vaccin
inadequ
field
trial
data
prior
releas
given
rise
seriou
consequ
regard
safeti
unfortun
answer
question
often
reflect
individu
experi
vest
interest
disinclin
state
true
answer
known
estim
offic
visit
veterinarian
associ
vaccin
sever
vaccin
dog
cat
licens
poor
question
efficaci
yet
continu
produc
promot
eg
leptospira
bacterin
giardia
canin
coronaviru
ccv
vaccin
recent
past
sever
canin
parvoviru
vaccin
new
improv
vaccin
introduc
almost
yearli
yet
even
perfunctori
examin
reveal
spars
amount
data
often
overst
claim
particular
product
hand
question
pose
veterinarian
dog
owner
oppos
vaccin
philosoph
ground
often
defi
factual
answer
pauciti
publish
result
question
often
base
percept
valid
data
avail
also
mani
individu
accept
realiti
vaccin
medic
practic
sustain
risk
larg
extent
problem
standard
veterinari
vaccin
resist
solut
complex
inher
number
differ
vaccin
viral
strain
avail
pet
anim
poorli
character
author
share
belief
expect
vaccin
turn
point
hope
paper
provid
boost
address
import
problem
commentari
outlin
person
view
experi
note
unsettl
problem
point
difficulti
resolv
commonli
ask
question
notwithstand
remark
littl
impact
unless
veterinarian
act
gain
better
understand
vaccin
work
realist
appreci
problem
may
occur
hope
might
remedi
veterinari
vaccin
continu
develop
empir
technolog
avail
new
vaccin
doubtless
continu
develop
includ
subunit
vaccin
vector
recombin
vaccin
delet
mutant
nucleic
acid
plasmid
dna
vaccin
perhap
even
recombin
nosod
sic
made
avail
howev
merit
evalu
present
use
product
mere
sake
novelti
recombin
vaccin
eg
vacciniavector
rabi
wildlif
recent
licens
canari
poxvector
distemp
vaccin
lyme
diseas
vaccin
shown
merit
util
safeti
case
superior
efficaci
except
modifi
live
mlv
vaccin
common
product
use
worldwid
vaccin
compris
viru
strain
select
spontan
mutant
emerg
nativ
viral
popul
repeat
passag
cell
cultur
laboratori
host
major
mlv
vaccin
consist
viral
popul
contain
multipl
mutat
canin
vaccin
strain
biolog
clone
suppress
gener
nonimmun
mutant
laboratori
passag
vaccin
mutant
grow
intend
host
yet
replicationrestrict
critic
tissu
constitut
vaccin
differ
degre
loss
natur
virul
attenu
viru
nonimmun
mutant
also
may
emerg
laboratori
passag
variant
may
fail
grow
natur
host
yet
prolifer
luxuriantli
tissu
cultur
chick
embryo
attenu
mean
reduct
absolut
loss
capac
produc
diseas
safeti
problem
may
reveal
extens
field
test
conduct
unfortun
occur
product
licens
market
conspicu
exampl
failur
larg
number
dog
die
suffer
seriou
ill
follow
introduct
live
canin
coronaviru
ccc
vaccin
also
vaccin
judg
harmless
one
speci
may
provok
ill
anoth
one
uncertainti
absolut
safeti
certain
vaccin
eg
distemp
vaccin
strain
propag
canin
cell
cultur
live
viral
vaccin
recommend
wildlif
speci
pregnant
anim
unwean
pup
pup
ill
yet
breeder
veterinarian
continu
vaccin
pregnant
dam
pup
earli
week
age
use
vaccin
pet
speci
safeti
inform
limit
eg
ferret
efficaci
problem
persist
certain
primari
vaccin
canin
parvoviru
vaccin
certain
canin
distemp
product
howev
recent
improv
sever
canin
vaccin
especi
parvoviru
vaccin
previous
poor
margin
efficaci
greatli
improv
appear
provok
good
immun
respons
whether
improv
sustain
depend
larg
measur
care
taken
vaccin
produc
select
conserv
seed
stock
select
modern
approach
vaccin
address
section
follow
short
assess
statu
current
employ
vaccin
new
approach
immun
discuss
evid
efficaci
vaccin
use
anim
creat
almost
exclus
bacteri
viral
pathogen
parasit
diseas
continu
pose
especi
difficult
challeng
immunologist
current
recommend
vaccin
use
food
anim
equin
medicin
use
companion
anim
repres
mostli
kill
whole
cell
bacterin
inactiv
viru
live
attenu
bacteria
virus
subunit
synthet
peptid
toxoid
vaccin
produc
method
modif
method
employ
decad
sever
area
improv
use
somewhat
tradit
approach
new
technolog
evid
chlamydi
spirochet
dermatophyt
diseas
among
other
volp
cowork
describ
efficaci
immun
major
outer
membran
protein
chamydophila
cavia
aka
chlamydia
psittaci
chlamydi
vaccin
protect
infect
rather
amelior
symptom
attenu
live
omp
use
plasma
dna
offer
hope
success
even
recent
european
commiss
report
emphas
strategi
chlamydiosi
control
leptospirosi
lyme
diseas
vaccin
histori
success
sever
unfound
claim
princip
problem
leptospirosi
vaccin
larg
number
serovar
efficaci
serovar
contain
vaccin
lyme
diseas
vaccin
pose
similar
problem
vari
past
howev
recent
studi
use
multival
vaccin
encourag
vaccin
protect
dermatophytos
limit
success
recent
discoveri
new
group
immunostimul
antigen
open
avenu
explor
one
encourag
technolog
rapid
develop
method
isol
virul
gene
pathogen
insert
appropri
viral
vector
inject
host
muscl
tissu
allow
encod
virul
antigen
stimul
host
respons
discuss
accompani
paper
ml
michel
issu
one
quandari
veterinari
vaccin
import
food
anim
diseas
effect
vaccin
exist
util
current
surveil
procedur
depend
detect
host
immun
respons
vaccin
would
induc
bovin
tuberculosi
exampl
studi
orm
other
creat
hope
delay
hypersensit
respons
ppd
separ
protect
immun
respons
vector
dna
vaccin
tuberculosi
creat
protect
diseas
permit
tradit
skin
test
assess
preval
natur
infect
accompani
paper
pastoret
discuss
use
poxvirus
carrier
exogen
gene
stimul
protect
immun
respons
last
decad
bacteri
carrier
recent
yeast
pursu
order
direct
antigen
relev
host
lymphoid
tissu
exploit
abil
certain
salmonella
target
intestin
lymphoid
tissu
peyer
patch
curtiss
other
success
develop
vaccin
human
anim
use
alreadi
shown
efficaci
flock
herd
protect
trial
although
concern
even
prohibit
geneticallymodifi
food
human
food
chain
arntzen
cowork
pioneer
studi
creat
transgen
plant
introduc
gene
encod
virul
antigen
pathogen
number
foodstuff
success
approach
would
permit
inexpens
oral
immun
larg
herd
flock
scale
accomplish
rabi
vaccin
incorpor
artifici
synthet
food
current
success
gene
incorpor
realiz
banana
potato
howev
use
carrier
may
limit
anim
capabl
digest
uncook
veget
develop
monoclon
antibodi
present
immunologist
opportun
use
host
immun
system
whether
laboratori
mous
spleen
cell
definit
host
peripher
blood
lymphocyt
lymph
node
cell
amplifi
host
antibodi
produc
toward
immunolog
import
virul
determin
pathogen
massiv
amount
ident
antibodi
encourag
possibl
antibodi
could
produc
antigen
bind
site
antiidiotyp
thu
immun
host
monoclon
antibodi
could
potenti
provid
recipi
protect
virul
determin
pathogen
without
actual
exposur
agent
virul
antigen
negat
need
identifi
purifi
antigen
date
approach
produc
use
vaccin
candid
one
reason
reactiv
singl
virul
antigen
rare
effect
protect
diseas
need
cocktail
monoclon
direct
sever
differ
virul
marker
reduc
plausibl
approach
howev
waldmann
associ
demonstr
efficaci
use
monoclon
antibodi
graft
versu
host
cancer
therapi
may
applic
infecti
diseas
ampl
evid
literatur
efficaci
multival
vaccin
eg
clostridi
vaccin
sometim
combin
vaccin
one
coadministr
vaccin
result
enhanc
interfer
one
antigen
may
adjuv
effect
immun
respons
antigen
coadminist
suppress
effect
expand
effort
develop
subunit
vaccin
rais
concern
untoward
effect
administ
togeth
induc
autoimmun
reaction
host
tissu
would
observ
subunit
vaccin
administ
singli
tempor
space
larg
number
vaccin
administ
militari
personnel
embark
servic
arabian
gulf
caus
suggest
gulf
war
ill
resembl
autoimmun
etiolog
may
result
advers
reaction
multipli
administ
subunit
vaccin
genet
predispos
individu
low
incid
reaction
would
probabl
observ
larg
popul
immun
similar
time
autoimmun
reactiv
acut
onset
untoward
effect
anim
would
difficult
identifi
sinc
food
anim
short
product
life
span
data
larg
number
companion
anim
belong
mani
differ
owner
would
difficult
compil
thu
associ
immunologicallybas
diseas
pet
anim
singl
vaccin
prepar
would
imposs
without
advers
event
report
structur
mention
clearli
area
vaccinolog
requir
thorough
control
investig
industri
academ
research
rapidli
develop
new
mean
enhanc
immun
respons
vaccin
antigen
two
promis
avenu
investig
cholera
toxin
ct
modifi
labil
toxin
b
subunit
mltb
adjuv
use
cytokin
adjuv
first
describ
elson
eald
abl
break
oral
toler
use
ct
prove
highli
efficaci
human
oral
vaccin
trial
genet
modif
nativ
ctbltb
bind
subunit
result
better
host
toler
adjuv
equival
result
use
oral
administ
cytokin
activ
area
investig
follow
find
exogen
cytokin
administr
lymphotoxin
b
modul
immun
respons
stimul
expans
mucos
lymphoid
tissu
although
paper
critic
current
state
evalu
veterinari
vaccin
mani
success
especi
canin
vaccin
shortcom
mention
exist
import
canin
viral
infect
distemp
cd
problem
variabl
cd
vaccin
safeti
efficaci
persist
cd
vaccin
greatli
reduc
preval
diseas
case
vaccin
dog
rare
infecti
canin
hepat
ich
infect
also
well
control
vaccin
year
rare
sporad
case
seen
past
decad
usual
occur
unvaccin
dog
vaccin
continu
given
sinc
prove
safe
effect
prevent
hepat
well
adenovir
tracheobronch
failur
vaccin
would
like
result
increas
case
ich
seriou
diseas
never
signific
distemp
cpv
infect
distemp
vaccin
consid
core
vaccin
ie
vaccin
everi
dog
receiv
although
complex
domin
opinion
ye
question
respond
unequivoc
howev
sinc
manufactur
employ
differ
strain
vari
immun
capac
probabl
durat
immun
question
frequent
distemp
time
mani
veterinarian
test
batch
vaccin
use
provid
preand
postvaccin
sera
compet
diagnost
laboratori
practic
appear
benefit
veterinarian
dog
well
indirectli
qualiti
vaccin
unfortun
mani
owner
veterinarian
seem
hold
view
infecti
diseas
parvoviru
infect
control
frequent
vaccin
alon
less
emphasi
hygien
pup
isol
common
practic
dog
breeder
vaccin
anim
sever
time
year
senseless
revaccin
distemp
parvoviru
infect
suggest
year
age
recommend
regard
frequenc
vaccin
given
time
unclear
sinc
distemp
vaccin
probabl
provid
immun
endur
sever
year
vaccin
year
interv
first
year
seem
reason
practic
data
durat
immun
becom
avail
distemp
parvoviru
vaccin
essenti
canin
adenoviru
vaccin
recommend
sinc
case
brought
attent
recent
year
unvaccin
dog
vaccin
respiratori
infect
recommend
dog
especi
kennel
board
need
establish
coronaviru
vaccin
lyme
diseas
vaccin
use
prevent
ill
area
diseas
exist
unnecessari
elsewher
sinc
dog
respond
rapidli
appropri
antibiot
sever
leptospira
bacterin
without
benefit
sinc
contain
critic
serovar
fail
protect
area
recombin
ospa
vaccin
avail
lyme
diseas
ld
appear
safe
effect
least
year
caus
vaccineinduc
postvaccin
lame
document
certain
whole
cell
lyme
diseas
bacterin
lyme
diseas
vaccin
restrict
dog
enter
endem
area
infest
tick
resid
leptospirosi
vaccin
commonli
report
caus
anaphylaxi
note
sever
current
vaccin
contain
serovar
preval
region
vast
major
case
diagnos
new
york
state
diagnost
lab
cornel
univers
grippotyphosa
pomona
serovar
recent
case
caus
canicola
icterohemorrhagia
serovar
sinc
leptospirosi
import
diseas
dog
urgent
need
research
develop
safer
vaccin
contain
preval
serovar
mexico
dog
may
infect
sever
serovar
canin
vaccin
contain
serovar
conditio
sine
qua
non
avail
consist
good
vaccin
without
standard
vaccin
seem
difficult
formul
gener
vaccin
recommend
effort
direct
improv
standard
import
vaccin
current
use
develop
new
product
unless
need
demonstr
mention
introduct
public
becom
increasingli
awar
vaccin
problem
perhap
even
benefit
vaccin
realiti
vaccin
carri
risk
fulli
perceiv
mani
owner
veterinarian
altern
veterinari
medicin
grow
realiti
practic
taught
sever
veterinari
colleg
question
pertain
vaccin
safeti
efficaci
continu
vex
veterinarian
vaccinologist
vaccin
produc
address
need
better
appreci
risk
advers
reaction
final
issu
discuss
recommend
might
made
littl
influenc
unless
biolog
manufactur
regulatori
offici
exercis
greater
respons
control
vaccin
qualiti
could
encourag
appoint
committe
unbias
expert
review
vaccin
diseas
provid
recommend
base
avail
evid
view
discuss
meet
sever
occas
past
year
larg
neglect
consider
involv
industri
interest
indiffer
overburden
govern
author
trust
veterinarian
anim
owner
advertis
vaccin
vaccin
guidelin
physician
supervis
american
academi
pediatr
committe
infecti
diseas
advisori
committe
immun
practic
advis
medic
profess
regulatori
author
regular
review
vaccin
side
effect
contraind
advers
reaction
done
similar
cdc
human
vaccin
veterinari
profess
insist
respons
advisori
council
concern
question
regard
vaccin
continu
met
conflict
opinion
open
door
thing
shaman
nosod
thugawhos
benefit
seem
understood
use
profit
